Pfizer GLP-1 Drug Passes Preliminary Review For China’s Medical Insurance Drug List
Pfizer's GLP-1 drug passes preliminary review for China's medical insurance drug list.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.